- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting ferroptosis in melanoma: cancer therapeutics ; volume:21 ; number:1 ; day:23 ; month:11 ; year:2023 ; pages:1-16 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (23.11.2023), 1-16, 12.2023
- Creator
-
Khorsandi, Khatereh
Esfahani, HomaSadat
Ghamsari, Saeedeh Keyvani-
lakhshehei, Parisa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01296-w
- URN
-
urn:nbn:de:101:1-2024021309104662658068
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khorsandi, Khatereh
- Esfahani, HomaSadat
- Ghamsari, Saeedeh Keyvani-
- lakhshehei, Parisa
- SpringerLink (Online service)
Other Objects (12)
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Developing novel specific therapeutics targeting adipocytes
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Developing novel specific therapeutics targeting adipocytes
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Targeting ferroptosis in breast cancer
Targeting CDK9 for anti-cancer therapeutics
Melanoma : Biologically Targeted Therapeutics
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Metabolic reprogramming and targeting ferroptosis in breast cancer
Novel insights on targeting ferroptosis in cancer therapy
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Targeting prominin2 transcription to overcome ferroptosis resistance in cancer
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics